*Effects of Icosapent Ethyl on Plasma Ceramides and Coronary Plaque Progression in EVAPORATE trial

Autor: S Lakshmanan, TM Benanzer, J Meeusen, L Donato, DL Bhatt, A Kinninger, I Golub, S Kopecky, MC Hyun, CG Scott, JR Nelson, MJ Budoff, MK Ito, AS Jaffe, VC Vasile

Publikováno v: Journal of Clinical Lipidology. 16:e39

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::597d97e01f6b42585d628a09b93b1bd8
https://doi.org/10.1016/j.jacl.2022.05.013

Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.

Autor: Burger PM; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands., Dorresteijn JAN; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands., Fiolet ATL; Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.; Dutch Cardiovascular Research Network (WCN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands., Koudstaal S; Dutch Cardiovascular Research Network (WCN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands.; Department of Cardiology, Green Heart Hospital, Gouda, The Netherlands., Eikelboom JW; Department of Medicine, McMaster University, Hamilton, Canada., Nidorf SM; Department of Cardiology, GenesisCare Western Australia, Perth, Australia.; Heart Research Institute of Western Australia, Perth, Australia., Thompson PL; Department of Cardiology, GenesisCare Western Australia, Perth, Australia.; Heart Research Institute of Western Australia, Perth, Australia., Cornel JH; Dutch Cardiovascular Research Network (WCN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands.; Department of Cardiology, Radboud University Medical Centre, Nijmegen, The Netherlands., Budgeon CA; School of Population and Global Health, University of Western Australia, Perth, Australia., Westendorp ICD; Department of Cardiology, Red Cross Hospital, Beverwijk, The Netherlands., Beelen DPW; Department of Cardiology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands., Martens FMAC; Dutch Cardiovascular Research Network (WCN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands.; Department of Cardiology, Deventer Hospital, Deventer, The Netherlands., Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, Paris, France., Asselbergs FW; Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands., Cramer MJ; Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands., Teraa M; Department of Vascular Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, USA., Visseren FLJ; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands., Mosterd A; Dutch Cardiovascular Research Network (WCN), Moreelsepark 1, 3511 EP Utrecht, The Netherlands.; Department of Cardiology, Meander Medical Centre, Maatweg 3, 3813 TZ Amersfoort, The Netherlands.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2023 Dec 21; Vol. 30 (18), pp. 1950-1962.

Profile: Prof. Deepak L. Bhatt MD MPH FACC FAHA FESC.

Autor: Ozkan J

Publikováno v: European heart journal [Eur Heart J] 2014 Jul; Vol. 35 (26), pp. 1696-7.

The empirical support for the radical cure strategy for eliminating Plasmodium vivax in China.

Autor: Yang, Guo-Jing^1,2,3 (AUTHOR) guojingyang@hotmail.com, Shang, Le-Yuan⁴ (AUTHOR), Zhou, Xiao-Nong⁵ (AUTHOR), Lee, Tamsin E.^2,3 (AUTHOR), Bi, Bo¹ (AUTHOR), White, Michael⁶ (AUTHOR), Smith, Thomas A.^2,3 (AUTHOR), Penny, Melissa A.^2,3 (AUTHOR) melissa.penny@unibas.ch

Publikováno v: BMC Medicine. 1/21/2022, Vol. 20 Issue 1, p1-14. 14p.

Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.

Autor: Gibson CM; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Duffy D; CSL Behring, King of Prussia, PA, USA., Bahit MC; INECO Neurociencias Rosario, Argentina., Chi G; INECO Neurociencias Rosario, Argentina., White H; Health New Zealand Te Toka Tumai Auckland City Hospital, New Zealand., Korjian S; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Alexander JH; Duke Clinical Research Institute, Duke Health, Durham, NC, USA., Lincoff AM; The Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH  USA., Heise M; CSL Behring, King of Prussia, PA, USA., Kingwell BA; CSL Limited, Melbourne, Australia., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Lopes RD; Duke Clinical Research Institute, Duke Health, Durham, NC, USA.; Brazilian Clinical Research Institute, Sao Paulo, SP, Brazil., Cornel JH; Radboud University Medical Center, Nijmegen and Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands., Lewis BS; Lady Davis Carmel Medical Center, Haifa, Israel., Vinereanu D; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania., Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, St. Michael's Hospital, Unity Health Toronto, and Peter Munk Cardiac Center, University Health Network, University of Toronto, Canada., Bode C; Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Steg PG; Université Paris-Cité, INSERM U_1148, FACT and AP-HP, Hôpital Bichat, Paris, France., Libby P; Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Sacks FM; Harvard T. H. Chan School of Public Health, Brigham and Women's Hospital, Boston, MA, USA., Bainey KR; Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta, Canada., Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA, USA., Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA., Aylward P; South Australian Health and Medical Research Institute/SAHMRI, Adelaide, Australia., Nicholls SJ; Victorian Heart Institute, Monash University, VIC, Melbourne, Australia., Pocock SJ; London School of Hygiene and Tropical Medicine, London, UK., Mehran R; Icahn School of Medicine at Mount Sinai, Zena and Michael A. Wiener Cardiovascular Institute, New York, NY, USA., Harrington RA; Weill Cornell Medicine, New York, NY, USA.

Publikováno v: European heart journal [Eur Heart J] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.